Safety and efficacy results from iSABR, a phase 1 study of stereotactic ablative radiotherapy in combination with durvalumab for early-stage medically inoperable non-small cell lung cancer Research Letter
| Authors: | Wu, T. C.; Stube, A.; Felix, C.; Oseguera, D.; Romero, T.; Goldman, J.; Garon, E. B.; Lee, J. M.; Glaspy, J.; Lisberg, A. E.; Rusthoven, C. G.; Camidge, D. R.; Siva, S.; Solomon, B.; Lee, A.; Tenn, S. E.; Shaverdian, N.; Steinberg, M. L.; Raldow, A. C.; Lee, P. |
| Title: | Safety and efficacy results from iSABR, a phase 1 study of stereotactic ablative radiotherapy in combination with durvalumab for early-stage medically inoperable non-small cell lung cancer |
| Keywords: | cancer chemotherapy; controlled study; major clinical study; clinical trial; drug safety; follow up; cancer immunotherapy; multiple cycle treatment; carcinoma, non-small-cell lung; lung neoplasms; radiotherapy dosage; publication; monoclonal antibody; lung tumor; antibodies, monoclonal; lung adenocarcinoma; radiosurgery; patient safety; clinical effectiveness; phase 1 clinical trial; stereotactic body radiation therapy; national health organization; non small cell lung cancer; humans; human; male; female; article; squamous cell lung carcinoma; durvalumab |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 117 |
| Issue: | 1 |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | 118 |
| End Page: | 122 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2023.03.069 |
| PUBMED: | 37023987 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
